Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Virtuoso Surgical | 2026 | Venture - Series Unknown | Undisclosed | Nashville |
| Clene Nanomedicine | 2026 | Post-IPO Equity | Undisclosed | Salt Lake City |
| Quiver Bioscience | 2026 | Grant | Undisclosed | Cambridge |
| Psilera | 2026 | Seed | $3.0M | Tampa |
| Eliaz Therapeutics | 2026 | Equity Crowdfunding | $850K | Santa Rosa |
| Transcode Therapeutics | 2026 | Post-IPO Debt | Undisclosed | Newton |
| MAIA Biotechnology | 2026 | Post Ipo Equity | $30.0M | Chicago |
| Azitra | 2026 | Post Ipo Equity | $31.0M | Branford |
| Immuto Scientific | 2025 | Seed | $8.0M | Madison |
| Bright Uro | 2025 | Venture - Series Unknown | $14.7M | Aliso Viejo |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Virtuoso Surgical | Venture - Series Unknown | Undisclosed | Nashville, United States |
| 2 | Clene Nanomedicine | Post-IPO Equity | Undisclosed | Salt Lake City, United States |
| 3 | Quiver Bioscience | Grant | Undisclosed | Cambridge, United States |
| 4 | Psilera | Seed | $3.0M | Tampa, United States |
| 5 | Eliaz Therapeutics | Equity Crowdfunding | $850K | Santa Rosa, United States |
| 6 | Transcode Therapeutics | Post-IPO Debt | Undisclosed | Newton, United States |
| 7 | MAIA Biotechnology | Post Ipo Equity | $30.0M | Chicago, United States |
| 8 | Azitra | Post Ipo Equity | $31.0M | Branford, United States |
| 9 | Immuto Scientific | Seed | $8.0M | Madison, United States |
| 10 | Bright Uro | Venture - Series Unknown | $14.7M | Aliso Viejo, United States |
Virtuoso Surgical specializes in developing endoscopic robotic tools for minimally invasive surgery.
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
Psilera is a biotechnology company that develops treatments for neurological and psychiatric disorders.
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
Bright Uro is an early-stage medical technology company.
Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.
South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Actuated Medical is engaged in outsourced research and development, designing, modeling, prototyping, and manufacturing medical devices.
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
Epicore Biosystems is a digital health solutions company that develops sweat-sensing wearables, providing personalized health insights.
Ria Health is an online platform providing telehealth services for alcohol use disorder.
Peel Therapeutics is a biotech company that develops medicines for cancer and inflammatory diseases.
IotaMotion is a medical technology company developing robotics-assisted solutions for cochlear implant surgery.
Teal Health is a health tech company that develops cervical cancer screening and communication platforms.
PhotoniCare is a medical device company that develops diagnostic tools to improve clinical outcomes and address unmet patient needs.
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
NextStep Robotics is developing the first effective treatment option for foot drop to help stroke survivors.
Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.
Self-Driven Neurological Assessments
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Therapeutics. The firm invests across 27 different industry categories.
Among tracked funding rounds, Therini Bio received $39.0M in a Series A round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include Virtuoso Surgical, Clene Nanomedicine, Quiver Bioscience, Psilera, Eliaz Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors